Showing 3,981 - 4,000 results of 15,659 for search '(( significant decrease decrease ) OR ( significant i decrease ))~', query time: 0.85s Refine Results
  1. 3981
  2. 3982

    Fig 2 - by Maryann S. Watson (16879881)

    Published 2025
    Subjects:
  3. 3983
  4. 3984
  5. 3985
  6. 3986
  7. 3987
  8. 3988
  9. 3989
  10. 3990
  11. 3991

    <i>Oenocarpus bacaba</i> palm tree (A) and fruit (B). by Eudes Alves Simões-Neto (19697968)

    Published 2024
    “…Serological cure was achieved in 34.6% of cases, and IgG titers decreased in 15.3%.</p><p>Conclusions and significance</p><p>We encountered several barriers in managing ACD, including population vulnerability, reliance on outdated diagnostic techniques, lack of standardized molecular biology methods, and limited therapeutic options. …”
  12. 3992
  13. 3993

    Dam and pup body and brain weights. by Adrienne J. Bradley (20861948)

    Published 2025
    “…<p><b>(A)</b> and <b>(B)</b> Weight of dams and pups were not significantly different from PBS controls. <b>(C)</b> Pup brain weight decreased significantly with Pg exposure (Mann-Whitney U p =  0.023). …”
  14. 3994
  15. 3995
  16. 3996

    Flowchart of the screening process. by Huixia Ren (500186)

    Published 2025
    “…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”
  17. 3997

    Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

    Published 2025
    “…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”
  18. 3998

    Characteristics of included reviews. by Huixia Ren (500186)

    Published 2025
    “…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”
  19. 3999

    Result of the PRISMA assessments. by Huixia Ren (500186)

    Published 2025
    “…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”
  20. 4000

    Result of the ROBIS assessments. by Huixia Ren (500186)

    Published 2025
    “…Per ROBIS, all SRs/MAs exhibited low risk in phase 1 and domain 1 but high risk in domain 2. Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. …”